Olga
H
Toro-Salazar
MD, EMBA
Dr. Olga Toro-Salazar is a Pediatric Cardiologist and Professor of Pediatrics at Vanderbilt University Medical Center, where she directs the Cardio-Oncology and Dimensional Cardiac Imaging Programs at Monroe Carell Jr. Children’s Hospital. Her career has been dedicated to advancing cardiovascular care for children and young adults with congenital and acquired heart disease, with a particular focus on patients facing the combined challenges of cancer and cardiovascular disease.
As an expert in advanced cardiac imaging, myocardial mechanics, and precision cardio-oncology, Dr. Toro-Salazar’s work emphasizes early detection of cardiotoxicity, survivorship care, and development of data-driven clinical models. Her vision for Vanderbilt includes building a national model for pediatric precision cardio-oncology supported by AI-enhanced risk prediction, cloud-based registries, standardized imaging protocols, and integrated biomarker and genomic
Doctors' Office Tower
2200 Children's Way
Nashville
Tennessee
37232-9119
Dr. Toro-Salazar is actively expanding a comprehensive research program centered on precision cardio-oncology, advanced cardiac imaging, digital health interventions, and multicenter collaboration.
Her primary project, “Improving Cardiovascular Outcomes of Pediatric, Adolescent, and Young Adult Cancer Survivors with Implementation of Precision Cardio-Oncology Care” integrates precision medicine and AI models into clinical practice. With IRB submission underway, the project includes development of a cloud-based registry for real-time patient monitoring and aims to leverage real-world data to improve cardiovascular outcomes in cancer survivors.
Dr. Toro-Salazar is also leading a study evaluating the “Feasibility of a Personalized Home Exercise Trial Using a Mobile App to Improve Cardiorespiratory Fitness in Childhood Cancer Survivors”. Pilot work is complete, with an R34 grant planned for June 2026.
Use of Integrated Statistical Modeling Using Early CMR-Derived Imaging Biomarkers of Adverse Remodeling to Improve Prediction and Prevention of Cardiotoxicity Progression and Mortality*, focuses on developing advanced predictive imaging models. An R34/R01 application is planned for October 2026.
Dr. Toro-Salazar leads the Imaging in Cardiac Hematology Oncology Research (ICHOR) Consortium, a multicenter collaborative network that drives innovation in multimodality imaging for pediatric cancer patients. ICHOR-affiliated hospitals include Connecticut Children’s (lead), Nationwide Children’s Hospital, Le Bonheur Children’s Hospital, Vanderbilt Children’s Hospital, St. Jude Children’s Research Hospital, Cincinnati Children’s Hospital Medical Center, Duke Children’s Hospital & Health Center, Children’s National Hospital, and Ann & Robert H. Lurie Children’s Hospital of Chicago. Her 2026 goals include development of a shared registry through ImageCHD for standardized multicenter imaging data collection.
https://www.ncbi.nlm.nih.gov/myncbi/olga.toro-salazar.1/bibliography/pu…
olga.torosalazar@vumc.org
MD
Universidad Javeriana, Bogota, Columbia
Residency
Pediatrics - University of Connecticut, Farmington, Conn.
Fellowship
Pediatric Cardiology - University of Minnesota, Minneapolis
Cardiac MRI Fellowship - Boston Children's Hospital, Boston
